Yes for Pfizer Booster for Over 65 and at Risk


Figure: Francois Monier / AFP (Getty Images)

A few weeks later I wonder who can get covid-19 booster shots and when — and receive confusing advice from various sources government officials-The Food and Drug Administration officials have made a decision.

On Wednesday, FDA regulators decided to abruptly change the license for Pfizer-BioNTech and allow only one shot of its covid-19 vaccine to be given to other groups of people. These groups are: people 65 years of age or older; people between the ages of 18 and 64 who are at high risk of taking covid-19; and people between the ages of 18 and 64 in other organizations or activities that put them at risk of taking covid-19 or other complications.

Although the first two groups are well cut, the third group is smaller, which is why agency officials decided to provide examples. FDA chief executive Janet Woodcock said the group includes health workers, teachers, day care workers, food buyers, prison inmates, and homeless people, among others.

The agency’s decision only applies to Pfizer-BioNTech’s covid-19 vaccine, which is vaccine alone approval in this country. It should be noted that the boost is the third dose of Pfizer-BioNTech vaccine. It’s not a shooter.

“The epidemic is changing and evolving, with new information on vaccine safety and supporting its daily availability,” Woodcock said in a statement. “As we learn more about the safety and efficacy of the COVID-19 vaccine, as well as the use of complementary drugs, we will continue to test the rapidly changing science and inform people.”

According to the timeframe, the FDA said the supplements could be given to people in groups of at least six months after receiving a list of two groups and at any time thereafter.

Safety and safety risks were assessed by Pfizer in a clinical trial of 318 people. Participants, 306 who were between the ages of 18 and 55 while 12 were over the age of 65, were monitored for two months. The side effects of the recording were similar to those reported after the first dose and included pain, redness and swelling at the injection site; fatigue; head; muscles and bones; and cold. The FDA also reported that participants experienced swollen lymph nodes in their hands frequently after the shooting.

The decision follows a meeting between Vaccines and the Export Advisory Committee, an external advisory panel last week. voted against approves the shooting of Americans over the age of 16. The committee unanimously agreed to encourage people over the age of 65 and others at high risk of covid-19. The ruling was eventually reversed by the FDA – as well as the Centers for Disease Control and Prevention, which has not yet commented on it – because the committee’s vote did nothing.

The FDA’s idea is to throw a wrench into Biden’s management plan to provide an eagle for most Americans. The US is a very rich country Agreeing to shoot its citizens, joining Germany, France, Britain, and Israel.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *